AcceLINX to Collaborate with AMB Surgical on Novel Orthopedic Technology
AcceLINX, a musculoskeletal health business accelerator, and AMB Surgical II, LLC, Dayton, OH, have entered into an agreement whereby AcceLINX will provide consulting services to assist in the technical and regulatory development of AMB Surgical’s novel, smart automated growing rod.
According to AMB Surgical, the FLYTE™ Smart Automated Growing Rod (SAGR) has the potential to revolutionize treatment of scoliosis and long-bone deformities. AMB Surgical uses patented technology to electronically control the extension of rods used to direct skeletal alignment. For scoliosis treatment, the FLYTE SAGR would allow the physician to expand implanted spinal rods remotely, reducing the need for additional corrective surgeries. For long-bone deformity correction procedures, it would eliminate the need for manual adjustments to external frames, as well as reduce the likelihood of missing adjustments. FLYTE SAGR offers the promise of reduced surgical trauma, improved ease of use, better patient outcomes, and reduced cost of care.
AMB Surgical’s Chief Executive Officer Dan Sands said the company recognizes the need for additional resources to support development and alignment with strategic commercialization partners for its innovative technology.
“We appreciate the level and scope of orthopedic medical device expertise that is available from AcceLINX to round out our team,” Mr. Sands said. “We are quickly seeing the advantages of engaging with this group of highly skilled and experienced industry professionals.”
Sheryl Conley, AcceLINX President, AMB Surgical’s technology has excellent clinical and commercial potential. “We are really excited about the technology that AMB Surgical has developed so far,” said Ms. Conley. “We look forward to working with their accomplished team to achieve a fully functioning prototype, the next key milestone in the company’s evolution expected later this year.”
Representatives from AcceLINX and AMB Surgical will be attending the AAOS Annual Meeting in New Orleans from March 7-9 and would welcome an opportunity to meet with parties interested in either the smart automated growing rod technology or in AcceLINX’s business acceleration services.
About AMB Surgical II, LLC.
Comprising a team of elite engineers and orthopedic industry experts, AMB Surgical is devoted to the development and commercialization of its FLYTE™ smart automated growing rod technology which holds promise to reduce anxiety and trauma from juvenile and adolescent surgeries. The invasive nature of surgery is, in itself, a difficult reality and one that impedes an individual’s ability to comfortably enjoy life. AMB Surgical’s groundbreaking, patented technology is intended to reduce the necessity for invasive and repetitive surgery in children and teens with orthopedic deformities such as scoliosis and limb abnormalities. FLYTE is a sophisticated electro-mechanical, software activated device to provide real-time biomechanical feedback to guide treatment, as well as allow surgeons to perform accurate, non-surgical skeletal adjustments. Through our work, AMB Surgical is advancing the boundaries of modern medicinal practices.
AcceLINX, a multistage musculoskeletal health business accelerator, was conceived and launched by OrthoWorx to provide an unmatched level of industry-specific support to select inventors and entrepreneurs looking to enhance their prospects of business success. AcceLINX leverages the unprecedented concentration of medical device industry resources in northern Indiana and the deep industry expertise and global networks of its team members to provide a unique capacity to accelerate the results of start-ups it engages with. Learn more about AcceLINX online.
Formed in 2009 with initial funding from the Lilly Endowment, OrthoWorx is a community-based initiative that works strategically and collaboratively with the orthopedic industry and other stakeholders to ensure that the Warsaw region continues to reap the social and economic benefits that derive from its position as “The Orthopedic Capital of the World.”